Compare $AKTX vs $KTTA | Chartloom

Compare

$AKTX vs $KTTA

Akari Therapeutics PLC · Pasithea Therapeutics Corp

AKTX

Akari Therapeutics PLC

KTTA

Pasithea Therapeutics Corp

Compare $AKTX vs $KTTA

Comparing Akari Therapeutics PLC and Pasithea Therapeutics Corp

AKTXAkari Therapeutics PLC

KTTAPasithea Therapeutics Corp

AKTXAkari Therapeutics PLC

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-24.4%

52W performance

-78.5%

FCF yield

-63.0%

KTTAPasithea Therapeutics Corp

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

740.5%

YTD performance

-60.7%

52W performance

-43.0%

FCF yield

-113.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTX

KTTA

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

KTTA

Pasithea Therapeutics Corp

Market Cap

AKTX$17M

KTTA$16M

Enterprise Value

AKTX$10M

KTTA$-30M

Price

AKTX$8.77

KTTA$0.47

P/E Ratio

AKTXN/A

KTTAN/A

P/S Ratio

AKTX0.00x

KTTA26.84x

EV/Sales

AKTX0.00x

KTTA0.00x

EV/EBITDA

AKTX0.00x

KTTA0.00x

P/B Ratio

AKTX0.83x

KTTA0.32x

P/FCF Ratio

AKTXN/A

KTTAN/A

EV/FCF

AKTX-0.94x

KTTA1.69x

PEG Ratio

AKTXN/A

KTTAN/A

Forward P/E (NTM)

AKTXN/A

KTTAN/A

Forward P/S (NTM)

AKTXN/A

KTTAN/A

Revenue (TTM)

AKTX$0

KTTA$0

Revenue Growth (YoY)

AKTXN/A

KTTA740.5%

Forward Rev Growth

AKTX137.9%

KTTA0.0%

Gross Margin (TTM)

AKTX0.0%

KTTA100.5%

Operating Margin (TTM)

AKTX0.0%

KTTA0.0%

EBITDA Margin (TTM)

AKTX0.0%

KTTA0.0%

Net Margin (TTM)

AKTX0.0%

KTTA0.0%

FCF Margin (TTM)

AKTXN/A

KTTAN/A

Net Income (TTM)

AKTX$-31M

KTTA$-21M

FCF (TTM)

AKTX$-11M

KTTA$-18M

EPS (TTM)

AKTX-$0.40

KTTA-$0.66

ROE (TTM)

AKTX-14745.0%

KTTA-4949.0%

ROA (TTM)

AKTX-7470.0%

KTTA-4681.0%

ROIC (TTM)

AKTX-14027.0%

KTTA-4949.0%

Cash

AKTX$8M

KTTA$46M

Debt

AKTX$693K

KTTA$0

Net Cash/Debt

AKTX$7M

KTTA$46M

Current Ratio (TTM)

AKTX0.60x

KTTA26.25x

Quick Ratio (TTM)

AKTX0.56x

KTTA24.91x

Debt/Equity (TTM)

AKTX0.04x

KTTA0.00x

Debt/Assets (TTM)

AKTX0.0%

KTTA0.0%

Interest Coverage (TTM)

AKTXN/A

KTTAN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

KTTA0.00x

Beta

AKTX1.48

KTTA0.39

52W Performance

AKTX-78.5%

KTTA-43.0%

YTD Performance

AKTX-24.4%

KTTA-60.7%

% from 52W High

AKTX-79.5%

KTTA-77.3%

% from 52W Low

AKTX190.4%

KTTA66.4%

Asset Turnover (TTM)

AKTX0.00x

KTTA0.01x

FCF Yield (TTM)

AKTX-63.0%

KTTA-113.8%

Earnings Yield (TTM)

AKTX-181.3%

KTTA-136.3%

Dividend Yield (TTM)

AKTXN/A

KTTAN/A

Rule of 40

AKTX0.0

KTTA740.5

EV/GP/RG

AKTXN/A

KTTAN/A

Ticker research

View AKTX research View KTTA research

Metric	AKTX Akari Therapeutics PLC	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$17M	$16M
Enterprise Value	$10M	$-30M
Price	$8.77	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.84x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	137.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-21M
FCF (TTM)	$-11M	$-18M
EPS (TTM)	-$0.40	-$0.66
ROE (TTM)	-14745.0%	-4949.0%
ROA (TTM)	-7470.0%	-4681.0%
ROIC (TTM)	-14027.0%	-4949.0%
Financial Health
Cash	$8M	$46M
Debt	$693K	$0
Net Cash/Debt	$7M	$46M
Current Ratio (TTM)	0.60x	26.25x
Quick Ratio (TTM)	0.56x	24.91x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.39
52W Performance	-78.5%	-43.0%
YTD Performance	-24.4%	-60.7%
% from 52W High	-79.5%	-77.3%
% from 52W Low	190.4%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-63.0%	-113.8%
Earnings Yield (TTM)	-181.3%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	740.5
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View KTTA research

Valuation

P/S Ratio

AKTX

0.00x

KTTA

26.84x

EV/FCF

AKTX

-0.94x

KTTA

1.69x

Growth & revenue

Revenue Growth TTM

KTTA

740.5%

Forward Revenue Growth

AKTX

137.9%

KTTA

0.0%

Profitability & performance

Gross Margin

KTTA

100.5%

AKTX

0.0%

ROE

KTTA

-4949.0%

AKTX

-14745.0%

FCF Yield %

AKTX

-63.0%

KTTA

-113.8%

52-Week Performance

KTTA

-43.0%

AKTX

-78.5%

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

KTTA

Pasithea Therapeutics Corp

Market Cap

AKTX$17M

KTTA$16M

Enterprise Value

AKTX$10M

KTTA$-30M

Price

AKTX$8.77

KTTA$0.47

P/E Ratio

AKTXN/A

KTTAN/A

P/S Ratio

AKTX0.00x

KTTA26.84x

EV/Sales

AKTX0.00x

KTTA0.00x

EV/EBITDA

AKTX0.00x

KTTA0.00x

P/B Ratio

AKTX0.83x

KTTA0.32x

P/FCF Ratio

AKTXN/A

KTTAN/A

EV/FCF

AKTX-0.94x

KTTA1.69x

PEG Ratio

AKTXN/A

KTTAN/A

Forward P/E (NTM)

AKTXN/A

KTTAN/A

Forward P/S (NTM)

AKTXN/A

KTTAN/A

Revenue (TTM)

AKTX$0

KTTA$0

Revenue Growth (YoY)

AKTXN/A

KTTA740.5%

Forward Rev Growth

AKTX137.9%

KTTA0.0%

Gross Margin (TTM)

AKTX0.0%

KTTA100.5%

Operating Margin (TTM)

AKTX0.0%

KTTA0.0%

EBITDA Margin (TTM)

AKTX0.0%

KTTA0.0%

Net Margin (TTM)

AKTX0.0%

KTTA0.0%

FCF Margin (TTM)

AKTXN/A

KTTAN/A

Net Income (TTM)

AKTX$-31M

KTTA$-21M

FCF (TTM)

AKTX$-11M

KTTA$-18M

EPS (TTM)

AKTX-$0.40

KTTA-$0.66

ROE (TTM)

AKTX-14745.0%

KTTA-4949.0%

ROA (TTM)

AKTX-7470.0%

KTTA-4681.0%

ROIC (TTM)

AKTX-14027.0%

KTTA-4949.0%

Cash

AKTX$8M

KTTA$46M

Debt

AKTX$693K

KTTA$0

Net Cash/Debt

AKTX$7M

KTTA$46M

Current Ratio (TTM)

AKTX0.60x

KTTA26.25x

Quick Ratio (TTM)

AKTX0.56x

KTTA24.91x

Debt/Equity (TTM)

AKTX0.04x

KTTA0.00x

Debt/Assets (TTM)

AKTX0.0%

KTTA0.0%

Interest Coverage (TTM)

AKTXN/A

KTTAN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

KTTA0.00x

Beta

AKTX1.48

KTTA0.39

52W Performance

AKTX-78.5%

KTTA-43.0%

YTD Performance

AKTX-24.4%

KTTA-60.7%

% from 52W High

AKTX-79.5%

KTTA-77.3%

% from 52W Low

AKTX190.4%

KTTA66.4%

Asset Turnover (TTM)

AKTX0.00x

KTTA0.01x

FCF Yield (TTM)

AKTX-63.0%

KTTA-113.8%

Earnings Yield (TTM)

AKTX-181.3%

KTTA-136.3%

Dividend Yield (TTM)

AKTXN/A

KTTAN/A

Rule of 40

AKTX0.0

KTTA740.5

EV/GP/RG

AKTXN/A

KTTAN/A

Ticker research

View AKTX research View KTTA research

Metric	AKTX Akari Therapeutics PLC	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$17M	$16M
Enterprise Value	$10M	$-30M
Price	$8.77	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.84x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	137.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-21M
FCF (TTM)	$-11M	$-18M
EPS (TTM)	-$0.40	-$0.66
ROE (TTM)	-14745.0%	-4949.0%
ROA (TTM)	-7470.0%	-4681.0%
ROIC (TTM)	-14027.0%	-4949.0%
Financial Health
Cash	$8M	$46M
Debt	$693K	$0
Net Cash/Debt	$7M	$46M
Current Ratio (TTM)	0.60x	26.25x
Quick Ratio (TTM)	0.56x	24.91x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.39
52W Performance	-78.5%	-43.0%
YTD Performance	-24.4%	-60.7%
% from 52W High	-79.5%	-77.3%
% from 52W Low	190.4%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-63.0%	-113.8%
Earnings Yield (TTM)	-181.3%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	740.5
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View KTTA research